Tiny study on drug monitoring in scleroderma ends early
NCT ID NCT04244916
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study aimed to see if measuring the amount of a drug called mycophenolic acid in the blood could help doctors adjust doses to better treat skin and lung problems in people with systemic sclerosis. Only 2 people joined before the study was stopped early. Because of the small number of participants, no clear conclusions could be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin hospital, AP-HP
Paris, France, 75014, France
Conditions
Explore the condition pages connected to this study.